MAM
PR story comes full circle as veteran pens India’s five-decade journey
MUMBAI: From press releases to power moves, Public Relations in India has been on quite the rollercoaster and now its story has been bound between covers. Communication veteran Ganapathy Viswanathan, who has spent over 30 years shaping brands at Ogilvy, Lintas, Mudra and Publicis, has launched a new book chronicling PR’s dramatic transformation across five decades.
What began in the 1970s as a little-understood function has now grown into a strategic juggernaut that drives reputation, navigates crises, and even influences elections and sport. Viswanathan’s book captures this arc with real-world anecdotes and practical insights that make it both a guide for the young and a mirror for industry stalwarts.
“PR today is about building trust, telling authentic stories, and engaging meaningfully with audiences across platforms. This book is my tribute to a profession that has the power to shape perceptions, influence decisions, and create lasting impact,” said Viswanathan at the launch.
The chapters don’t shy away from today’s burning questions either: the talent crunch, the shifting roles of influencers and journalists, and how empathy has become as critical as strategy.
For students, it’s a crash course in a craft that’s moved beyond “spin.” For professionals, it’s a reminder that PR is now central to boardrooms, not just newsrooms. And for India’s communication industry at large, it’s a milestone marker charting how far PR has come, and how much further it could go.
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
